Search Results | Cancer Research | American Association for Cancer Research

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Abstract P6-04-07: Time-course DNA and RNA profiling reveals down regulation of all members of the sulfotransferase A1 subfamily during neoadjuvant therapy with aromatase inhibitors

Charles Vaske, Rahul Parulkar, Nazli Bahrami, Torill Sauer, Torben Lüders, Annika Lorentzen, Berit Gravdehaug, Vessela Kristensen, Jürgen Geisler

Cancer Res (2020) 80 (4_Supplement): P6-04-07.

DOI: https://doi.org/10.1158/1538-7445.SABCS19-P6-04-07

Published: 15 February 2020

View article

Journal Articles

Abstract 2533: The genomic and transcriptomic landscape of left versus right sided breast cancer in 410 cases

Yulia Newton, Christopher Szeto, Charles Vaske, Leia Reddy, Sandeep Reddy

Cancer Res (2019) 79 (13_Supplement): 2533.

DOI: https://doi.org/10.1158/1538-7445.AM2019-2533

Published: 01 July 2019

View article

Journal Articles

Abstract 2253: Identifying pathogenic germline variants in 1,172 cancer patients utilizing a novel variant phasing tool and strict public database curation

Amanda Polley, Charles Vaske, Steve Benz, Patrick Soon-Shiong, Shahrooz Rabizadeh, J Zachary Sanborn

Cancer Res (2018) 78 (13_Supplement): 2253.

DOI: https://doi.org/10.1158/1538-7445.AM2018-2253

Published: 01 July 2018

View article

Journal Articles

Abstract 3381: Determining the relationship between a measure of stress-induced mutagenesis and patient survival in cancer

Luis Cisneros, Charles Vaske, Kimberly J. Bussey

Cancer Res (2018) 78 (13_Supplement): 3381.

DOI: https://doi.org/10.1158/1538-7445.AM2018-3381

Published: 01 July 2018

View article

Journal Articles

Abstract 3888: The NantOmics Pharmacogenomics Test: An integrative panomic approach to pharmacogenomics screening

Camille Schwartz, John Little, Charles Vaske, Stephen Benz, Patrick Soon-Shiong, Shahrooz Rabizadeh, J. Zachary Sanborn

Cancer Res (2018) 78 (13_Supplement): 3888.

DOI: https://doi.org/10.1158/1538-7445.AM2018-3888

Published: 01 July 2018

View article

Journal Articles

Abstract 393: Predicting DNA accessibility in the pan-cancer tumor genome using RNA-Seq, WGS, and deep learning

Kamil Wnuk, Jeremi Sudol, Shahrooz Rabizadeh, Patrick Soon-Shiong, Christopher Szeto, Charles Vaske

Cancer Res (2017) 77 (13_Supplement): 393.

DOI: https://doi.org/10.1158/1538-7445.AM2017-393

Published: 01 July 2017

View article

Journal Articles

Abstract 4165: Differential pathway activation associated with domain-specific PIK3CA mutations

Christina Yau, Stephen Benz, Charles Vaske, Sam Ng, Josh Stuart, Christopher C. Benz

Cancer Res (2014) 74 (19_Supplement): 4165.

DOI: https://doi.org/10.1158/1538-7445.AM2014-4165

Published: 01 October 2014

View article

Journal Articles

Abstract 1813: FOXM1 target genes associated with cell cycle regulation predict breast cancer metastatic outcome.

Christina Yau, Laurence Meyer, Stephen Benz, Charles Vaske, Gary Scott, Brian Egan, Paul Labhart, Elizabeth Mitchell, Nader Pourmand, Christopher Benz

Cancer Res (2013) 73 (8_Supplement): 1813.

DOI: https://doi.org/10.1158/1538-7445.AM2013-1813

Published: 15 April 2013

View article

Journal Articles

Abstract 2985: Predicting the impact of mutations in cancer using an integrated pathway approach

Sam Ng, Janita Thusberg, Stephen Benz, Charles Vaske, Kyle Ellrott, Jing Zhu, Christina Yau, Eric Collisson, Sean Mooney, Christopher Benz, David Haussler, Joshua Stuart

Cancer Res (2012) 72 (8_Supplement): 2985.

DOI: https://doi.org/10.1158/1538-7445.AM2012-2985

Published: 15 April 2012

View article

Journal Articles

Abstract 4905: Patient-specific pathway analysis using PARADIGM identifies key activities in multiple cancers

Stephen C. Benz, Charles Vaske, Sam Ng, John Zachary Sanborn, Jing Zhu, David Haussler, Joshua Stuart

Cancer Res (2011) 71 (8_Supplement): 4905.

DOI: https://doi.org/10.1158/1538-7445.AM2011-4905

Published: 15 April 2011

View article

Journal Articles

Abstract 4985: The UCSC Cancer Genomics Browser

Jingchun Zhu, J. Zachary Sanborn, Stephen C. Benz, Brian Craft, Christopher Szeto, Kord M. Kober, Mary Goldman, Laurence Meyer, Charles Vaske, Eric Collisson, Joshua Stuart, David Haussler

Cancer Res (2011) 71 (8_Supplement): 4985.

DOI: https://doi.org/10.1158/1538-7445.AM2011-4985

Published: 15 April 2011

View article

Journal Articles

Abstract 43: Using matrix factorization to discover clinically-relevant molecular signatures across cancers

Christopher W. Szeto, Jingchun Zhu, James Durbin, Stephen Benz, Charles Vaske, Joshua Stuart, David Haussler

Cancer Res (2011) 71 (8_Supplement): 43.

DOI: https://doi.org/10.1158/1538-7445.AM2011-43

Published: 15 April 2011

View article

Journal Articles

Abstract 5292: Role of voltage-gated Na⁺ channels in the metastatic potential of colon cancer cells

Carrie House, Charles Vaske, Arnold Schwartz, Vincent Obias, Narine Sarvazyan, Tim Hales, Joshua Stuart, Norman Lee

Cancer Res (2010) 70 (8_Supplement): 5292.

DOI: https://doi.org/10.1158/1538-7445.AM10-5292

Published: 15 April 2010

View article

Journal Articles

Abstract 2015: Patient-specific pathway analysis using DIGMA identifies key activities in multiple cancers

Stephen Benz, Charles Vaske, J. Zachary Sanborn, Joshua Stuart, David Haussler

Cancer Res (2010) 70 (8_Supplement): 2015.

DOI: https://doi.org/10.1158/1538-7445.AM10-2015

Published: 15 April 2010

View article

Journal Articles

Abstract 2001: Non-negative matrix factorization (NMF) as a clinical classifier: An example with chemotherapy response in ovarian cancer

Szeto Christopher, Stephen Benz, Charles Vaske, J. Zachary Sanborn, Jing Zhu, Joshua Stuart, David Haussler

Cancer Res (2010) 70 (8_Supplement): 2001.

DOI: https://doi.org/10.1158/1538-7445.AM10-2001

Published: 15 April 2010

View article

NARROW

Abstract P6-04-07: Time-course DNA and RNA profiling reveals down regulation of all members of the sulfotransferase A1 subfamily during neoadjuvant therapy with aromatase inhibitors

Abstract 2533: The genomic and transcriptomic landscape of left versus right sided breast cancer in 410 cases

Abstract 2253: Identifying pathogenic germline variants in 1,172 cancer patients utilizing a novel variant phasing tool and strict public database curation

Abstract 3381: Determining the relationship between a measure of stress-induced mutagenesis and patient survival in cancer

Abstract 3888: The NantOmics Pharmacogenomics Test: An integrative panomic approach to pharmacogenomics screening

Abstract 393: Predicting DNA accessibility in the pan-cancer tumor genome using RNA-Seq, WGS, and deep learning

Abstract 4165: Differential pathway activation associated with domain-specific PIK3CA mutations

Abstract 1813: FOXM1 target genes associated with cell cycle regulation predict breast cancer metastatic outcome.

Abstract 2985: Predicting the impact of mutations in cancer using an integrated pathway approach

Abstract 4905: Patient-specific pathway analysis using PARADIGM identifies key activities in multiple cancers

Abstract 4985: The UCSC Cancer Genomics Browser

Abstract 43: Using matrix factorization to discover clinically-relevant molecular signatures across cancers

Abstract 5292: Role of voltage-gated Na⁺ channels in the metastatic potential of colon cancer cells

Abstract 2015: Patient-specific pathway analysis using DIGMA identifies key activities in multiple cancers

Abstract 2001: Non-negative matrix factorization (NMF) as a clinical classifier: An example with chemotherapy response in ovarian cancer

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only